麥克森 MCK 深 滬
已收盤 12-12 16:00:00 美东时间
813.80
-1.740
-0.21%
華盛通- 最 高826.00
- 今 開818.46
- 成交量 101.03万股
- 最 低 812.00
- 昨 收 815.54
- 總市值 1000.97亿
- 52周最高 894.76
- 市盈率 靜 31.64
- 換手率 0.82%
- 52周最低 562.69
- 委 比 -45.45%
- 總股本 1.23亿
- 歷史最高 894.76
- 量 比 1.22
- 振 幅 1.72%
- 歷史最低 45.57
- 每 手 1
- 風險率 77.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 21.85%...
12-06 00:45
Iterum Therapeutics Provides Business Update
Iterum Therapeutics plc announced business updates, including expanded reimbursement access for ORLYNVAH™ reaching nearly 25% of U.S. insured lives, a signed rebate agreement with a top Medicare Part D Pharmacy Benefits Manager for potential Q1 2026 coverage, and the addition of Cencora as a specialty distributor. The European Patent Office granted a patent for a sulopenem etzadroxil-probenecid bilayer tablet, expiring in December 2039. The compa...
12-05 13:00
Iterum Therapeutics Provides Business Update
<p>Iterum Therapeutics has announced updates on its business, including the stocking of ORLYNVAH™ at McKesson and the FDA clearance of its sulopenem susceptibility disc. ORLYNVAH™ is now available through McKesson's specialty distribution channel, allowing physicians to procure the product directly. The FDA-cleared disc, manufactured by Liofilchem®, is intended for use in microbiology laboratories for susceptibility testing to determine Enterobac...
11-24 13:00
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 24.3% ...
11-22 07:45
Freeport-McMoRan, Cisco, Teradyne And A Health Care Stock: CNBC's 'Final Trades'
Freeport-McMoRan, Cisco, Teradyne and McKesson each get a shoutout on the latest edition of CNBC's 'Final Trades.'
11-20 21:04
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile w...
11-19 01:59
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Baird Maintains Outperform on McKesson, Raises Price Target to $927
Baird analyst Eric Coldwell maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $873 to $927.
11-07 01:38
公司簡介
公司名稱
|
麦克森
|
行業分類
|
医药商店
|
業務描述
|
作为美国历史最悠久，规模最大的医疗保健服务公司，麦克森药物批发公司在医疗保健方面起着不可或缺的作用，并对医疗保健未来的发展拥有独特的见解。麦克森为美国超过50％的医院，20％的医生和96％的首二十五位的健康计划提供服务，作为北美最大的医药分销商，每天使用的药物有三分之一是由麦克森公司提供的。
公司的软件，配送和商业服务在解决医疗机构面临的挑战中起到了至关重要的作用。
|
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 21.85%...
12-06 00:45
Iterum Therapeutics Provides Business Update
Iterum Therapeutics plc announced business updates, including expanded reimbursement access for ORLYNVAH™ reaching nearly 25% of U.S. insured lives, a signed rebate agreement with a top Medicare Part D Pharmacy Benefits Manager for potential Q1 2026 coverage, and the addition of Cencora as a specialty distributor. The European Patent Office granted a patent for a sulopenem etzadroxil-probenecid bilayer tablet, expiring in December 2039. The compa...
12-05 13:00
Iterum Therapeutics Provides Business Update
<p>Iterum Therapeutics has announced updates on its business, including the stocking of ORLYNVAH™ at McKesson and the FDA clearance of its sulopenem susceptibility disc. ORLYNVAH™ is now available through McKesson's specialty distribution channel, allowing physicians to procure the product directly. The FDA-cleared disc, manufactured by Liofilchem®, is intended for use in microbiology laboratories for susceptibility testing to determine Enterobac...
11-24 13:00
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 24.3% ...
11-22 07:45
Freeport-McMoRan, Cisco, Teradyne And A Health Care Stock: CNBC's 'Final Trades'
Freeport-McMoRan, Cisco, Teradyne and McKesson each get a shoutout on the latest edition of CNBC's 'Final Trades.'
11-20 21:04
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile w...
11-19 01:59
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Baird Maintains Outperform on McKesson, Raises Price Target to $927
Baird analyst Eric Coldwell maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $873 to $927.
11-07 01:38
派息除權日
|
每股總股息
| 派息日期 |
2025-12-01
|
0.82
|
2026-01-02
|
2025-09-02
|
0.82
|
2025-10-01
|
2025-06-02
|
0.71
|
2025-07-01
|
2025-03-03
|
0.71
|
2025-04-01
|
2024-12-02
|
0.71
|
2025-01-02
|
2024-08-30
|
0.71
|
2024-10-01
|
2024-06-03
|
0.62
|
2024-07-01
|
2024-02-29
|
0.62
|
2024-04-01
|
2023-11-30
|
0.62
|
2024-01-02
|
2023-08-31
|
0.62
|
2023-10-02
|
2023-05-31
|
0.54
|
2023-07-03
|
2023-02-28
|
0.54
|
2023-04-03
|
2022-11-30
|
0.54
|
2023-01-03
|
2022-08-31
|
0.54
|
2022-10-03
|
2022-05-31
|
0.47
|
2022-07-01
|
2022-02-28
|
0.47
|
2022-04-01
|
2021-11-30
|
0.47
|
2022-01-03
|
2021-08-31
|
0.47
|
2021-10-01
|
2021-05-28
|
0.42
|
2021-07-01
|
2021-03-01
|
0.42
|
2021-04-01
|
2020-11-30
|
0.42
|
2021-01-04
|
2020-08-31
|
0.42
|
2020-10-01
|
2020-05-29
|
0.41
|
2020-07-01
|
2020-02-28
|
0.41
|
2020-04-01
|
2019-11-29
|
0.41
|
2020-01-02
|
2019-08-30
|
0.41
|
2019-10-01
|
2019-05-31
|
0.39
|
2019-07-01
|
2019-02-28
|
0.39
|
2019-04-01
|
2018-11-30
|
0.39
|
2019-01-02
|
2018-08-31
|
0.39
|
2018-10-01
|
2018-05-31
|
0.34
|
2018-07-02
|
2018-02-28
|
0.34
|
2018-04-02
|
2017-11-30
|
0.34
|
2018-01-02
|
2017-08-30
|
0.34
|
2017-10-02
|
2017-06-01
|
0.28
|
2017-07-03
|
2017-02-27
|
0.28
|
2017-04-03
|
2016-11-29
|
0.28
|
2017-01-02
|
2016-08-30
|
0.28
|
2016-10-03
|
2016-06-02
|
0.28
|
2016-07-01
|
2016-02-26
|
0.28
|
2016-04-01
|
2015-11-27
|
0.28
|
2016-01-04
|
2015-08-28
|
0.28
|
2015-10-01
|
2015-06-04
|
0.24
|
2015-07-01
|
2015-02-26
|
0.24
|
2015-04-01
|
2014-11-26
|
0.24
|
2015-01-02
|
2014-08-28
|
0.24
|
2014-10-01
|
2014-06-05
|
0.24
|
2014-07-01
|
2014-02-27
|
0.24
|
2014-04-01
|
2013-11-27
|
0.24
|
2014-01-02
|
2013-08-29
|
0.24
|
2013-10-01
|
2013-06-05
|
0.20
|
2013-07-01
|
2013-02-27
|
0.20
|
2013-04-01
|
2012-11-29
|
0.20
|
2013-01-02
|
2012-08-30
|
0.20
|
2012-10-01
|
2012-06-06
|
0.20
|
2012-07-02
|
2012-02-28
|
0.20
|
2012-04-02
|
2011-11-29
|
0.20
|
2012-01-03
|
2011-08-30
|
0.20
|
2011-10-03
|
2011-06-08
|
0.20
|
2011-07-01
|
2011-02-25
|
0.18
|
2011-04-01
|
2010-11-29
|
0.18
|
2011-01-03
|
2010-08-30
|
0.18
|
2010-10-01
|
2010-06-08
|
0.18
|
2010-07-01
|
2010-02-25
|
0.12
|
2010-04-01
|
2009-11-27
|
0.12
|
2010-01-04
|
2009-08-28
|
0.12
|
2009-10-01
|
2009-06-08
|
0.12
|
2009-07-01
|
2009-02-26
|
0.12
|
2009-04-01
|
2008-11-26
|
0.12
|
2009-01-02
|
2008-08-28
|
0.12
|
2008-10-01
|
2008-06-04
|
0.12
|
2008-07-01
|
2008-02-28
|
0.06
|
2008-04-01
|
2007-11-29
|
0.06
|
2008-01-02
|
2007-08-29
|
0.06
|
2007-10-01
|
2007-06-06
|
0.06
|
2007-07-02
|
2007-02-27
|
0.06
|
2007-04-02
|
2006-11-29
|
0.06
|
2007-01-02
|
2006-08-30
|
0.06
|
2006-10-02
|
2006-06-07
|
0.06
|
2006-07-03
|
2006-02-27
|
0.06
|
2006-04-03
|
2005-11-29
|
0.06
|
2006-01-03
|
2005-08-30
|
0.06
|
2005-10-03
|
2005-06-08
|
0.06
|
2005-07-01
|
2005-02-25
|
0.06
|
2005-04-01
|
2004-11-29
|
0.06
|
2005-01-03
|
2004-08-30
|
0.06
|
2004-10-01
|
2004-06-07
|
0.06
|
2004-07-01
|
2004-02-26
|
0.06
|
2004-04-01
|
2003-11-26
|
0.06
|
2004-01-02
|
2003-08-27
|
0.06
|
2003-10-01
|
2003-06-05
|
0.06
|
2003-07-01
|
2003-02-27
|
0.06
|
2003-04-01
|
2002-11-27
|
0.06
|
2003-01-02
|
2002-08-28
|
0.06
|
2002-10-01
|
2002-06-06
|
0.06
|
2002-07-01
|
2002-02-27
|
0.06
|
2002-04-01
|
2001-11-29
|
0.06
|
2002-01-02
|
2001-08-29
|
0.06
|
2001-10-01
|
2001-05-31
|
0.06
|
2001-07-02
|
2001-02-27
|
0.06
|
2001-04-02
|
2000-11-29
|
0.06
|
2001-01-02
|
2000-08-30
|
0.06
|
2000-10-02
|
2000-05-30
|
0.06
|
2000-07-03
|
2000-02-28
|
0.06
|
2000-04-03
|
1999-11-29
|
0.06
|
2000-01-03
|
1999-08-30
|
0.06
|
1999-10-01
|
1999-05-27
|
0.06
|
1999-07-01
|
1999-02-25
|
0.06
|
1999-04-01
|
1998-11-27
|
0.13
|
1999-01-04
|
1998-08-28
|
0.13
|
1998-10-01
|
1998-05-28
|
0.13
|
1998-07-01
|
1998-02-26
|
0.13
|
1998-04-01
|
1997-11-26
|
0.25
|
1998-01-02
|
1997-08-28
|
0.25
|
1997-10-01
|
1997-05-29
|
0.25
|
1997-07-01
|
1997-02-27
|
0.25
|
1997-04-01
|
1996-11-27
|
0.25
|
1997-01-02
|
1996-08-29
|
0.25
|
1996-10-01
|
1996-05-30
|
0.25
|
1996-07-01
|
1996-02-28
|
0.25
|
1996-04-01
|
1995-11-29
|
0.25
|
1996-01-02
|
1995-08-30
|
0.25
|
1995-10-02
|
1995-05-25
|
0.25
|
1995-07-03
|
1995-02-23
|
0.25
|
1995-04-03
|
1994-12-09
|
0.25
|
1995-01-03
|
1994-11-25
|
0.42
|
1995-01-03
|
1994-08-26
|
0.42
|
1994-10-03
|
1994-05-25
|
0.42
|
1994-07-01
|
1994-02-23
|
0.42
|
1994-04-01
|
1993-11-24
|
0.42
|
1994-01-04
|
1993-08-26
|
0.42
|
1993-10-01
|
1993-05-25
|
0.40
|
1993-07-01
|
1993-02-23
|
0.40
|
1993-04-01
|
1992-11-24
|
0.40
|
1993-01-04
|
1992-08-26
|
0.40
|
1992-10-01
|
1992-05-26
|
0.40
|
1992-07-01
|
1992-02-25
|
0.40
|
1992-04-01
|
1991-11-25
|
0.40
|
1992-01-02
|
1991-08-27
|
0.40
|
1991-10-01
|
1991-05-28
|
0.40
|
1991-07-01
|
1991-02-25
|
0.40
|
1991-04-01
|
1990-11-27
|
0.40
|
1991-01-02
|
1990-08-28
|
0.40
|
1990-10-01
|
1990-05-25
|
0.40
|
1990-07-02
|
1990-02-23
|
0.36
|
1990-04-02
|
1989-11-27
|
0.36
|
1990-01-02
|
1989-08-28
|
0.36
|
1989-10-02
|
1989-05-25
|
0.36
|
1989-07-03
|
1989-02-23
|
0.36
|
1989-04-03
|
1988-11-25
|
0.36
|
1989-01-03
|
1988-08-26
|
0.36
|
1988-10-03
|
1988-05-25
|
0.36
|
1988-07-01
|
1988-02-24
|
0.32
|
1988-04-01
|
1987-11-24
|
0.32
|
1988-01-04
|
1987-08-26
|
0.32
|
1987-10-01
|
1987-05-26
|
0.32
|
1987-07-01
|
1987-02-24
|
0.32
|
1987-04-01
|
1986-11-24
|
0.32
|
1987-01-02
|
1986-08-26
|
0.64
|
1986-10-01
|
1986-05-27
|
0.60
|
1986-07-01
|
1986-02-25
|
0.60
|
1986-04-01
|
1985-11-25
|
0.60
|
1986-01-02
|
1985-08-27
|
0.60
|
1985-10-01
|
1985-05-28
|
0.60
|
1985-07-01
|
1985-02-25
|
0.60
|
1985-04-01
|
1984-11-27
|
0.60
|
1985-01-02
|
1984-08-28
|
0.60
|
1984-10-01
|
1984-05-25
|
0.60
|
1984-07-02
|
1984-02-24
|
0.60
|
1984-04-02
|
1983-11-25
|
0.60
|
1984-01-03
|
